BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10211795)

  • 1. Comparison of long-term survival of cytomegalovirus promotre versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancer.
    Tong X; Engehausen DG; Freund CT; Agoulnik I; Oehler MK; Kim TE; Hasenburg A; Guo Z; Contant CF; Woo SL; Kieback DG
    Hybridoma; 1999 Feb; 18(1):93-7. PubMed ID: 10211795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter.
    Freund CT; Tong XW; Block A; Contant CF; Kieback DG; Rowley DR; Lerner SP
    Anticancer Res; 2000; 20(5A):2811-6. PubMed ID: 11062688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter.
    Tong X; Engehausen DG; Freund CT; Agoulnik I; Guo Z; Oehler MK; Kim TE; Hasenburg A; Contant CF; Woo SL; Kieback DG
    Anticancer Res; 1998; 18(2A):719-25. PubMed ID: 9615711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Animal experiment on gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration in vivo].
    Tong X; Sei W; Gu M
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):712-4. PubMed ID: 9772431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
    Sutton MA; Berkman SA; Chen SH; Block A; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Woo SL; Lerner SP
    Urology; 1997 Feb; 49(2):173-80. PubMed ID: 9037277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
    Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG
    Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration.
    Tong XW; Block A; Chen SH; Contant CF; Agoulnik I; Blankenburg K; Kaufman RH; Woo SL; Kieback DG
    Gynecol Oncol; 1996 May; 61(2):175-9. PubMed ID: 8626129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific transcriptional targeting of suicide gene therapy.
    Qiao J; Doubrovin M; Sauter BV; Huang Y; Guo ZS; Balatoni J; Akhurst T; Blasberg RG; Tjuvajev JG; Chen SH; Woo SL
    Gene Ther; 2002 Feb; 9(3):168-75. PubMed ID: 11859419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
    Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
    Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.
    Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A
    Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer.
    Yee D; McGuire SE; BrĂ¼nner N; Kozelsky TW; Allred DC; Chen SH; Woo SL
    Hum Gene Ther; 1996 Jun; 7(10):1251-7. PubMed ID: 8793549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent adenovirus-mediated thymidine kinase gene expression in ovarian cancer cells increases cell killing efficacy over time.
    Kieback DG; Delvoux B; Romano A; Ollig S; Fischer DC
    Anticancer Res; 2008; 28(5A):2569-75. PubMed ID: 19035280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
    Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
    BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir.
    Tong XW; Block A; Chen SH; Woo SL; Kieback DG
    Anticancer Res; 1996; 16(4A):1611-7. PubMed ID: 8712678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy.
    Tong XW; Agoulnik I; Blankenburg K; Contant CF; Hasenburg A; Runnebaum LB; Stickeler E; Kaplan AL; Woo SL; Kieback DG
    Anticancer Res; 1997; 17(2A):811-3. PubMed ID: 9137412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP; Li BJ; Zhang C
    Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter.
    Pramudji C; Shimura S; Ebara S; Yang G; Wang J; Ren C; Yuan Y; Tahir SA; Timme TL; Thompson TC
    Clin Cancer Res; 2001 Dec; 7(12):4272-9. PubMed ID: 11751529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.